Provex CV

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

Citrus bioflavonoids extract, Quantity: 16.6 mg; Ginkgo biloba, Quantity: 16.67 mg (Equivalent: Ginkgo biloba, Qty 833.33 mg; Equivalent: Ginkgolides and bilobalide, Qty 1 mg; Equivalent: Ginkgo flavonglycosides, Qty 4 mg); papain, Quantity: 22.66 mg; Vaccinium myrtillus, Quantity: 333 microgram (Equivalent: Vaccinium myrtillus, Qty 33.3 mg); bromelains, Quantity: 1.019 million PU; Reynoutria japonica, Quantity: 40 mg (Equivalent: Reynoutria japonica, Qty 4 g; Equivalent: Resveratrol (of Reynoutria japonica), Qty 20 mg); Camellia sinensis, Quantity: 41.67 mg (Equivalent: Camellia sinensis, Qty 1.0417 g; Equivalent: Epigallocatechin-3-0-gallate, Qty 12.5 mg; Equivalent: caffeine, Qty 4.17 mg; Equivalent: catechins (of Camellia sinensis), Qty 25 mg); Vitis vinifera, Quantity: 70.18 mg (Equivalent: Vitis vinifera, Qty 8421.6 mg)

Prieinama:

Melaleuca of Australia and New Zealand Pty Ltd

INN (Tarptautinis Pavadinimas):

Bromelains,Camellia sinensis,Citrus bioflavonoids extract,Ginkgo biloba,Papain,Reynoutria japonica,Vaccinium myrtillus,Vitis vin

Vaisto forma:

Capsule, hard

Sudėtis:

Excipient Ingredients: colloidal anhydrous silica; ethylcellulose; maltodextrin; microcrystalline cellulose; purified water; crospovidone; magnesium stearate; croscarmellose sodium; hypromellose; lactose monohydrate; calcium hydrogen phosphate dihydrate; liquid paraffin

Vartojimo būdas:

Oral

Terapinės indikacijos:

Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Maintain/support cardiovascular system health ; Maintain/support heart health ; Maintain/support blood capillary health ; Maintain/support blood vessel health

Produkto santrauka:

Visual Identification: ;

Autorizacija statusas:

Licence status A

Leidimo data:

2015-07-15